Måndag 24 Augusti | 22:34:19 Europe / Stockholm
Est. tid*
2026-11-05 08:00 Kvartalsrapport 2026-Q3
2026-08-20 - Kvartalsrapport 2026-Q2
2026-05-08 - X-dag ordinarie utdelning MCLR 0.00 SEK
2026-05-07 - Kvartalsrapport 2026-Q1
2026-02-19 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-08-21 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning MCLR 0.00 SEK
2025-05-08 - Kvartalsrapport 2025-Q1
2025-04-16 - Årsstämma
2025-02-28 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-09 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-04-19 - X-dag ordinarie utdelning MCLR 0.00 SEK
2024-04-18 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-11 - X-dag ordinarie utdelning MCLR 0.00 SEK
2023-05-11 - Årsstämma
2023-05-10 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-05-05 - Kvartalsrapport 2022-Q1
2022-04-07 - X-dag ordinarie utdelning MCLR 0.00 SEK
2022-04-06 - Årsstämma
2022-02-23 - Bokslutskommuniké 2021
2021-08-19 - Kvartalsrapport 2021-Q2
2021-06-02 - X-dag ordinarie utdelning MCLR 0.00 SEK
2021-03-03 - Extra Bolagsstämma 2021
2021-02-23 - Bokslutskommuniké 2020
2020-08-19 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning MCLR 0.00 SEK
2020-06-10 - Årsstämma
2020-02-21 - Bokslutskommuniké 2019
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-22 - X-dag ordinarie utdelning MCLR 0.00 SEK
2019-05-21 - Årsstämma
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning MCLR 0.00 SEK
2018-05-16 - Årsstämma
2018-02-16 - Bokslutskommuniké 2017
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning MCLR 0.00 SEK
2017-05-18 - Årsstämma
LandSverige
ListaNordic SME Sweden
SektorHandel & varor
IndustriSällanköpsvaror
Medclair är ett svenskt cleantech-bolag som utvecklar teknik för hållbar hantering av lustgas inom sjukvård, återvinningsindustri och andra branscher med lustgasanvändning. Bolaget har en etablerad internationell närvaro och erbjuder lösningar som ämnar till att både minska klimatpåverkan och förbättra arbetsmiljön. Huvudkontoret ligger i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Medclair receives a new order worth approximately 12 MSEK in the UK

2026-08-20 08:32:00

Medclair has received a new order from a leading player in the recycling sector. The order value amounts to approximately 12 MSEK and pertains to the UK market. Parts of the order include an installation in Scotland, which means that Medclair is establishing itself in a new geographical market.

Through the new order, Medclair continues to gain ground in the recycling sector, a segment where the company has built a stable and growing customer base in several European countries in recent years. With the installation in Scotland, Medclair's technology for the recycling sector is now in place in England, Scotland, Ireland, Belgium, France, Denmark, and Sweden.

The order confirms the demand Medclair sees in the recycling segment and strengthens the company's position as an established provider of solutions for nitrous oxide destruction for players in waste management and recycling in the UK and the rest of Europe.

"Taking on Scotland as a new market is clear proof that our technology for safe and sustainable nitrous oxide management is in broad demand within the recycling sector, both in the UK and in the rest of Europe. Recycling has in a short time developed into one of our most important growth areas, and together with dental and healthcare, we now have three stable business areas – industry, dental, and healthcare – to rely on in our continued expansion," says Jonas Lundh, CEO of Medclair.

Medclair's three business areas – industry, dental, and healthcare – provide the company with a broader revenue base and reduce its dependence on individual segments or markets. The recycling sector, which is part of the industry business area, has grown over the past year to become a significant part of the order intake and contributes to spreading the company's geographical and commercial risk.

Jonas Lundh
CEO
Medclair AB